Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00025532
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer

Who this might be right for
Colorectal CancerEsophageal CancerGastric Cancer+1 more
University of California, San Francisco
Early research (Phase 1)Looking for participantsNCT07277413
What this trial is testing

IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Who this might be right for
NSCLC AdenocarcinomaGastroesophageal Cancer (GC)Gastric Adenocarcinoma+10 more
IDEAYA Biosciences 260
Testing effectiveness (Phase 2)Study completedNCT00003760
What this trial is testing

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The University of Texas Health Science Center at San Antonio 3
Testing effectiveness (Phase 2)Ended earlyNCT04975516
What this trial is testing

Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8Recurrent Pancreatic Adenocarcinoma+1 more
Mayo Clinic 2
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableEnrolling By InvitationNCT04875325
What this trial is testing

Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy

Who this might be right for
Resectable Pancreatic Ductal AdenocarcinomaRecurrent Pancreatic Ductal Adenocarcinoma
UMC Utrecht 306
Testing effectiveness (Phase 2)Study completedNCT00004190
What this trial is testing

Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 59
Not applicableStudy completedNCT06553040
What this trial is testing

The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreas Cancer
Ege University 87
Testing effectiveness (Phase 2)Study completedNCT00091026
What this trial is testing

Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 143
Large-scale testing (Phase 3)UnknownNCT00005871
What this trial is testing

Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Not applicableUnknownNCT00454376
What this trial is testing

Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
National Cancer Institute (NCI) 408
Not applicableStudy completedNCT01219829
What this trial is testing

Pancreatic Intraepithelial Neoplasia (PanIN) and the Association With Recurrence of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Columbia University 5
Testing effectiveness (Phase 2)Study completedNCT01465659
What this trial is testing

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Alpha Cell CarcinomaPancreatic Beta Islet Cell CarcinomaPancreatic Delta Cell Carcinoma+2 more
Northwestern University 29
Early research (Phase 1)Active Not RecruitingNCT00878163
What this trial is testing

GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmPancreatic Acinar Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00002773
What this trial is testing

Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
St. Vincent Medical Center - Los Angeles
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Testing effectiveness (Phase 2)Active Not RecruitingNCT05915351
What this trial is testing

Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreas AdenocarcinomaPancreas Cancer
University of Kansas Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT01339754
What this trial is testing

Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06773130
What this trial is testing

HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
West China Hospital 20
Next Page